Dedalus & IBEX launch AI pathology for cancer diagnosis in Europe
Dedalus and Ibex Launch an End-to-End AI-powered Digital Pathology Solution, Streamlining Cancer Diagnosis Across Europe
Milan, Italy, Nov 30th – Dedalus Group (“Dedalus”), the leading anatomic pathology information systems provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the launch of a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis.
The new solution is now commercially available in major European markets and sets a new standard for anatomic pathology lab digitization by seamlessly integrating Ibex’s GalenTM platform into Dedalus’ comprehensive Digital Pathology (DP) Solution. It enables full digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) & DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses.